CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 3,000 common shares valued at $147
CTTH•CEO buys shares in open-market transaction
CTT Pharmaceutical Holdings reported CEO Ryan Khouri bought 3,000 CTTH shares in an open-market purchase.
- The shares were bought at $0.05 each.
